ACTs	adoptive cell transfer therapies
APCs	antigen presenting cells
AR	androgen receptor
CRISPR	clustered regularly interspaced short palindromic repeats
CRPC	castration resistant prostate cancer
EBRT	external bean radiation therapy
EMT	epithelial-mesenchymal transition
ERG	ETS-related gene; GR glucocorticoid receptor
mCRPC	metastatic castration resistant prostate cancer
MDSC	myeloid derived suppressor cell
NE-CRPC	neuroendocrine castration resistant prostate cancer
NK	natural killer cell
NSAIDs	non-steroidal anti- inflammatory drugs;
OS	overall survival
PAP	prostatic acid phosphatase
PCPT	prostate cancer prevention trial
PILS	prostate infiltrating lymphocytes
PSA	prostate specific antigen
RT	radiotherapy
SPOP	speckle type poz protein
TAM	tumor-associated macrophage
TILs	tumor infiltrating lymphocytes
TME	tumor microenvironment
TNBC	triple negative breast cancer